Introduction
============

Small incision sutureless pars plana vitrectomy techniques have dramatically changed the field of retinal surgery. A rapid increase in indications for small incision vitrectomy has been evident in recent years. The main advantages of 25-gauge pars plana vitrectomy incisions, when compared with standard 20-gauge sclerotomies, are faster wound healing, diminished conjunctival scarring, improved patient comfort, decreased postoperative inflammation, and shortened surgical time.[@b1-opth-7-423]--[@b4-opth-7-423] However, the sutureless aspect of the technique has unique risks, including wound leak, hypotony, less than adequate gas bubble size, and increased rate of endophthalmitis.[@b5-opth-7-423]--[@b7-opth-7-423] Further, postoperative hypotony, defined as intraocular pressure ≤ 5 mmHg, may lead to postoperative bleeding in diabetic patients as well as to choroidal and ciliochoroidal detachment,[@b8-opth-7-423] and may also explain the higher rate of endophthalmitis reported with perpendicular sclerotomies used in earlier small incision surgeries. Beveled incisions and newer vitrectomy systems have been introduced in an attempt to reduce the risk of postoperative hypotony and related complications. These have lowered the risk of hypotony, and may account for recent reports that small incision postoperative endophthalmitis rates are currently low (0.02%) and comparable with endophthalmitis rates following 20-gauge vitrectomy.[@b9-opth-7-423]--[@b11-opth-7-423] However, hypotony remains a frequent complication following 25-gauge vitrectomy surgery. Bamonte et al recently reported the appearance of hypotony on postoperative day one following 25-gauge vitrectomy to be as high as 13.1%.[@b12-opth-7-423]

Gas mixtures are often used in vitrectomy surgery to tamponade the retina. In 1973, Norton proposed the use of sulfur hexafluoride (SF~6~) gas to provide a longer-acting gas bubble for intraocular tamponade.[@b13-opth-7-423] The nonexpansile concentration of SF~6~ is reported to be 20%.[@b14-opth-7-423]

Because of potential sclerotomy leak, along with the possibility of decreased intraocular pressure and incomplete vitreous cavity fill after 25-gauge pars plana vitrectomy surgery, in this study we investigated whether the use of a slightly expansile concentration of SF~6~ would achieve a better postoperative gas fill and decrease the occurrence of postoperative hypotony.

Materials and methods
=====================

This study was approved by the institutional board review of the University of Louisville, KY, USA. Clinical charts of all consecutive patients who underwent 25-gauge pars plana vitrectomy by three surgeons (HK, TT, SS) with complete fluid/gas exchange at the University of Louisville from August 1, 2008, to May 1, 2010 were included. Clinical charts were reviewed, and patients were divided retrospectively into two groups according to whether 20% or 25% SF~6~ gas was used as an internal tamponade at the conclusion of surgery. One surgeon (SS) used only 25% SF~6~ gas and two surgeons used 20% SF~6~ gas (HK, TT). [Table 1](#t1-opth-7-423){ref-type="table"} outlines the presurgical diagnoses. Data collection included patient age, indication for surgery, lens status, and intraocular pressure on postoperative day one using a tonopen (Tono-Pen AVIA tonometer, Reichert Technologies, NY, USA). If the intraocular pressure was lower than 6 mmHg or higher than 25 mmHg, it was measured again using Goldmann applanation tonometry. The amount of gas fill in the vitreous cavity on postoperative day one was assessed by the attending retinal specialist, and patients were instructed to maintain a face-down position for a week. Safety data included the incidence of wound leak needing suture placement at the time of surgery, and formation of cataract requiring surgical extraction during the follow-up period of one year. Patients younger than 18 years, those who did not complete the follow-up period, those who did not undergo ocular examination on postoperative day one, and those who had trauma to their eye in the first 24 hours after surgery were excluded.

All patients underwent three-port pars plana vitrectomy (Accurus, Alcon Laboratories Inc, Fort Worth, TX, USA) under general or local anesthesia, depending on patient and surgeon preference. The conjunctiva and Tenon's capsule were displaced away from the intended sclerotomy site using forceps or a cotton swab. All incisions were created in an oblique (beveled, angled) fashion 3.5--4 mm posterior to the limbus in pseudophakic and phakic patients, respectively. Once past the trocar sleeve, the angle was set perpendicular to the ocular surface and the cannula was inserted further into the eye. At the conclusion of surgery, all patients had complete fluid-air exchange using a soft tip instrument simultaneously with gas injection through the infusion cannula. The cannula was then extruded from the eye, the sclerotomy site was gently rubbed with a wet Q-tip, and the sclerotomy was assessed for gas leak by wetting with balanced salt solution. Leaking sclerotomies were sutured. The statistical analysis was carried out using the Statistical Package for Social Sciences software version 17.0 (SPSS Inc, Chicago, IL, USA). The statistical analysis was performed using oneway analysis of variance. *P* \< 0.05 was accepted as being statistically significant.

Results
=======

One hundred and eighty-seven patients who underwent 25-gauge pars plana vitrectomy surgery consecutively at the University of Louisville met our inclusion criteria. At the end of surgery, 50 patients had 20% SF~6~ as internal tamponade and 137 patients had the 25% SF~6~ gas mixture. Presurgical diagnoses and clinical data for the groups are summarized in [Table 1](#t1-opth-7-423){ref-type="table"}.

Five (10%) patients were diagnosed with hypotony (intraocular pressure ≤ 5 mmHg) on postoperative day one in the 20% SF~6~ group and none in the 25% SF~6~ group. Mean intraocular pressure ([Figure 1](#f1-opth-7-423){ref-type="fig"}) was 9 ± 2.5 (6--19) mmHg for the 20% SF~6~ group and 16.8 ± 2.4 (12--23) mmHg for the 25% SF~6~ group (*P* \< 0.01). No patient in either group suffered from high postoperative intraocular pressure requiring medication. Mean vitreous cavity gas fill ([Figure 2](#f2-opth-7-423){ref-type="fig"}) was 70.7% ± 10% and 89.5% ± 2.2% in the 20% SF~6~ and 25% SF~6~ groups, respectively (*P* \< 0.01). The frequency of sclerotomies needing suturing was low. There were three leaking sclerotomies requiring suturing in the SF~6~ 20% tamponade group and none in the SF~6~ 25% tamponade group. Three phakic patients (12%) needed cataract surgery during the one-year follow-up in the 20% SF~6~ group and seven (14%) in the 25% SF~6~ group. This difference was not statistically significant ([Table 2](#t2-opth-7-423){ref-type="table"}).

Discussion
==========

Pure SF~6~ gas expands to 1.9--2.0 times its original size because oxygen and nitrogen from the blood enter the gas bubble more rapidly than SF~6~ can leave the bubble. The most rapid expansion occurs over the first 6--8 hours, and maximal expansion is reached at around 24 hours. SF~6~ lasts in the eye for 10--14 days.[@b14-opth-7-423] As mentioned earlier, the nonexpansile concentration of SF~6~ is 20%.[@b14-opth-7-423] If the concentration of gas is greater than 20%, a portion of the gas equal to the difference in the concentration will expand 1.9--2.0 times. We used 25% SF~6~, so 5% of the gas could double in size. Assuming the volume of the vitreous cavity is 4 mL,[@b14-opth-7-423] 0.2 mL of the gas bubble doubles in size, resulting in an extra 0.2 mL of gas in the vitreous cavity during the first 24 hours after surgery. Tamponade with a slightly expansile concentration of 25% SF~6~ is ideal to prevent hypotony following sutureless small incision vitrectomy surgery. Even if some gas is lost through the sclerotomy in the immediate postoperative period, a portion of the gas bubble expands to keep the vitreous cavity full and normotonic.

Use of this slightly expansile concentration of gas as tamponade at the conclusion of 25-gauge pars plana vitrectomy surgery resulted in a statistically significant difference in intraocular pressure between the treatment groups on postoperative day one, and in the amount of gas present in the vitreous cavity. There were no cases of hypotony (≤5 mmHg) recorded in the group of patients receiving 25% SF~6~ compared with five cases (10%) in the group receiving 20% SF~6~. No patient developed postoperative endophthalmitis.

Use of 25% SF~6~ gas can prevent postoperative hypotony effectively in 25-gauge vitrectomies. A recent report by Kusuhara et al shows that leakage and hypotony remain a significant complication requiring frequent suturing of the sclerotomy in 23-gauge pars plana vitrectomy even with 25% SF~6~.[@b15-opth-7-423] Our different results using the 25-gauge system may stem from the different technique used, ie, introducing a trocar, but it is more likely that the 10% leak reported by Kusuhara et al was secondary to the 20% larger diameter of the 23-gauge trocar compared with the 25-gauge one (0.573 mm versus 0.455 mm). Hsu et al[@b10-opth-7-423] reported a 1.8%--10% rate of postoperative hypotony after 25-gauge vitrectomy, depending on the technique used for trocar insertion. We believe that hypotony, a potentially blinding complication of 25-gauge vitrectomy surgery, can be eliminated by combination of an oblique trocar insertion technique with infusion of 25% SF~6~ gas at the conclusion of surgery.

One common complication of vitrectomy surgery with the use of intraocular gas bubbles is cataract formation. Surgical removal of the vitreous body leads to accelerated formation of nuclear sclerotic cataracts.[@b16-opth-7-423],[@b17-opth-7-423] In a group of patients older than 50 years, 79% developed significant lens opacity in the surgical eye within 24 months.[@b18-opth-7-423] In the present study, the increased size of the gas bubble in the vitreous cavity did not cause a significant increase in cataract formation requiring extraction in the 25% SF~6~ group during the follow-up period (up to 24 months), and there was no difference in the rate of cataract extraction between the groups. Despite the expansile intraocular gas concentration in the 25% SF~6~ group, no excessive leak requiring suturing was noted, and the higher average intraocular pressure 16.8 mmHg (range 12--23mmHg) was well tolerated. None of the patients in this study suffered from high postoperative intraocular pressure requiring medication.

This retrospective research has some inherent limitations. One is that estimation of the amount of gas fill is a subjective measure, and can vary from observer to observer. However, there was still a statistically significant difference in the amount of gas fill between patients receiving 20% and 25% SF~6~ gas mixtures, and objective intraocular pressure measurement helps to confirm that the vitreous cavity is indeed more filled with gas. The advantages of this concentration of SF~6~ gas in preventing hypotony after sutureless vitrectomy should be investigated further in prospective studies.

In conclusion, a slightly expansile concentration of 25% SF~6~ can be used safely and beneficially in 25-gauge pars plana vitrectomy to increase the amount of gas fill in the vitreous cavity and to prevent postoperative hypotony and its related complications. This concentration should be considered routinely at the conclusion of 25-gauge pars plana vitrectomy.
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###### 

Diagnoses and clinical data

                                                      20% SF~6~   25% SF~6~   Total
  --------------------------------------------------- ----------- ----------- -------
  Number of patients                                  50          137         187
  Eye                                                                         
   Right                                              31          75          106
   Left                                               19          62          81
  Diagnosis                                                                   
   RR D[\*](#tfn2-opth-7-423){ref-type="table-fn"}    38          73          111
   Macular hole                                       9           22          31
   ERM[\*\*](#tfn3-opth-7-423){ref-type="table-fn"}   2           19          21
   Other                                              1           23          24
  Lens status                                                                 
   Phakic                                             25          49          74
   Pseudo-phakic                                      25          88          113

**Notes:**

Rhegmatogenous retinal detachment;

epiretinal membrane.

###### 

Phakic patients requiring cataract extraction within a year (*P* = 0.23)

              Number of phakic patients   Needed cataract surgery
  ----------- --------------------------- -------------------------
  20% SF~6~   25                          3
  25% SF~6~   49                          7
